These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21469765)

  • 21. Non-acne dermatologic indications for systemic isotretinoin.
    Akyol M; Ozçelik S
    Am J Clin Dermatol; 2005; 6(3):175-84. PubMed ID: 15943494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple eruptive dermatofibromas in a patient receiving efalizumab.
    Santos-Juanes J; Coto-Segura P; Mallo S; Galache C; Soto J
    Dermatology; 2008; 216(4):363. PubMed ID: 18292655
    [No Abstract]   [Full Text] [Related]  

  • 23. Isotretinoin-induced skin fragility in a teenaged athlete: a case report.
    Pavlis MB; Lieblich L
    Cutis; 2013 Jul; 92(1):33-4. PubMed ID: 23961523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of retinoids in dermatology].
    Brzezińska-Wcisło L; Pierzchała E; Kamińska-Budzińska G; Bergler-Czop B; Trzmiel D
    Wiad Lek; 2004; 57(1-2):63-9. PubMed ID: 15181752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What's new in pediatric dermatology in 2011?].
    Hadj-Rabia S
    Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S245-52. PubMed ID: 22202646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key developments in dermatology.
    Stollery N
    Practitioner; 2004 Sep; 248(1662):603-6, 608. PubMed ID: 15376545
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methotrexate in dermatology: pharmacology, indications, applications and prudent use].
    Lebrun-Vignes B; Bachelez H; Chosidow O
    Rev Med Interne; 1999 Aug; 20 Suppl 3():384s-392s. PubMed ID: 10480190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European Society for Dermatological Research--34th Annual Meeting. 9-11 September 2004, Vienna, Austria.
    Korstanje C
    IDrugs; 2004 Nov; 7(11):994-5. PubMed ID: 15551171
    [No Abstract]   [Full Text] [Related]  

  • 30. [Warning of a resistant psoriasis; looking beyond the usual].
    Franco-Muñoz M; Cortina-de la Calle MP; Flores-Terry M; Sanz-Trenado J
    Semergen; 2017 Oct; 43(7):521-523. PubMed ID: 28511882
    [No Abstract]   [Full Text] [Related]  

  • 31. Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris.
    Reilly BK; Ritsema TS
    JAAPA; 2015 Jul; 28(7):34-9. PubMed ID: 26107793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond Psoriasis: Novel Uses for Biologic Response Modifiers in Pediatric Dermatology.
    Bellodi-Schmidt F; Shah KN
    Pediatr Dermatol; 2016; 33(1):18-27. PubMed ID: 26607958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American Academy of Dermatology-68th annual meeting. 5-9 March 2010, Miami Beach, FL, USA.
    Whang T; Goldenberg G
    IDrugs; 2010 May; 13(5):311-3. PubMed ID: 20432186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comment on: "Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis".
    Chen S; Chen Y
    Am J Clin Dermatol; 2023 Sep; 24(5):853-854. PubMed ID: 38036747
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biologics in skin diseases other than psoriasis].
    Gniadecki R; Skov L
    Ugeskr Laeger; 2008 Jun; 170(24):2126-8. PubMed ID: 18565293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood generalized pustular psoriasis: successful treatment with isotretinoin.
    Al-Shobaili H; Al-Khenaizan S
    Pediatr Dermatol; 2007; 24(5):563-4. PubMed ID: 17958816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 67th annual meeting of the American Academy of Dermatology: San Francisco, California, USA, 6-10 March 2009.
    Fraser K
    Am J Clin Dermatol; 2009; 10(3):205-10. PubMed ID: 19354337
    [No Abstract]   [Full Text] [Related]  

  • 39. The field effect.
    Silverberg NB
    Cutis; 2011 May; 87(5):215-6. PubMed ID: 21699119
    [No Abstract]   [Full Text] [Related]  

  • 40. Circumventing iPLEDGE: Circumventing ethical responsibility?
    Lee KC; Bercovitch L
    J Am Acad Dermatol; 2017 Dec; 77(6):1185-1187. PubMed ID: 29132856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.